🇺🇸 FDA
Pipeline program

SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile

PRIN - 20227EA9AN

Phase 3 small_molecule active

Quick answer

SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile for Major Depressive Disorder (MDD) is a Phase 3 program (small_molecule) at Vita (Europe) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Vita (Europe) Limited
Indication
Major Depressive Disorder (MDD)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials